Home
Madrigal Pharmaceuticals MDGL paid Crossroads Strategies $50K for lobbying in Q1 2026 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q1 2026
- Client
- Madrigal Pharmaceuticals
- Reported
- 26/04/20
Up 0.0% from last quarter
What else happened in Madrigal Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 03/01~04/30Madrigal Pharmaceuticals's other lobbying reports
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$380K
$380K
Reported 07/20
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$50K
$50K
Reported 07/19
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$60K
$60K
Reported 07/16
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$120K
$120K
Reported 07/15
for Q2
- Madrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
LobbyingMadrigal Pharmaceuticals
MDGL
$380K
$380K
Reported 04/24
for Q1